| |
| |
|
| Insider
Information: |
Macdonald John R |
| Relationship: |
Sr. VP, Research & Dev... |
| City: |
Bloomington |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
14,676 |
|
|
Indirect Shares
|
25,038 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,714 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
MGI Pharma Inc |
MOGN |
Sr. VP, Research & Dev... |
2005-07-15 |
14,676 |
2005-07-15 |
25,038 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2005-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
14,676 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2005-02-15 |
4 |
S |
$25.03 |
$506,868 |
D/D |
(20,250) |
11,676 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2005-02-15 |
4 |
OE |
$1.97 |
$39,948 |
D/D |
20,250 |
31,926 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2005-02-14 |
4 |
AS |
$25.00 |
$250,000 |
D/D |
(10,000) |
11,676 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2005-02-14 |
4 |
OE |
$2.29 |
$23,799 |
D/D |
10,000 |
21,676 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-05-26 |
4 |
AS |
$63.40 |
$1,016,017 |
D/D |
(16,025) |
5,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-05-26 |
4 |
OE |
$3.38 |
$69,944 |
D/D |
16,025 |
21,863 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-01-20 |
4/A |
S |
$46.24 |
$80,925 |
D/D |
(1,750) |
5,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-01-20 |
4 |
OE |
$5.75 |
$10,063 |
D/D |
1,750 |
7,588 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-01-20 |
4 |
S |
$46.24 |
$80,925 |
D/D |
(1,750) |
5,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2004-01-20 |
4/A |
OE |
$5.75 |
$10,063 |
D/D |
1,750 |
7,588 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2003-12-22 |
4 |
S |
$40.05 |
$240,320 |
D/D |
(6,000) |
5,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2003-12-22 |
4 |
OE |
$5.75 |
$48,750 |
D/D |
6,000 |
11,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2003-11-20 |
4 |
S |
$37.64 |
$225,840 |
D/D |
(6,000) |
5,838 |
|
- |
|
| MOGN |
MGI Pharma Inc |
Sr. VP, Research & Development |
• – – |
2003-11-20 |
4 |
OE |
$5.75 |
$48,750 |
D/D |
6,000 |
11,838 |
|
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
